Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga January 07, 2016 at 08:28 AM EST Caladrius Biosciences Inc (NASDAQ: CLBS) shares fell 32.08 percent to $0.72 in pre-market trading after the company reported that it ... Read More >> Related Stocks: Akebia Therapeutics Epizyme Inc KB Home Microchip Technology The Finish Line, Inc. - Class A Common Stock